期刊论文详细信息
Arthritis Research & Therapy
Linked decreases in liver kinase B1 and AMP-activated protein kinase activity modulate matrix catabolic responses to biomechanical injury in chondrocytes
Freyr Petursson4  Matt Husa3  Ron June1  Martin Lotz2  Robert Terkeltaub4  Ru Liu-Bryan4 
[1] Mechanical and Industrial Engineering Department, Montana State University, PO Box 173800 Bozeman, MT 59717-3800, USA
[2] The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
[3] Department of Medicine, The Ohio State University, 480 Medical Center Drive, Columbus, OH 43210, USA
[4] VA San Diego Healthcare System, Department of Medicine, University of California San Diego, 111K, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
关键词: nitric oxide;    MMP-3;    aging;    cartilage;    osteoarthritis;   
Others  :  795617
DOI  :  10.1186/ar4254
 received in 2012-10-31, accepted in 2013-07-25,  发布年份 2013
PDF
【 摘 要 】

Introduction

AMP-activated protein kinase (AMPK) maintains cultured chondrocyte matrix homeostasis in response to inflammatory cytokines. AMPK activity is decreased in human knee osteoarthritis (OA) chondrocytes. Liver kinase B1 (LKB1) is one of the upstream activators of AMPK. Hence, we examined the relationship between LKB1 and AMPK activity in OA and aging cartilages, and in chondrocytes subjected to inflammatory cytokine treatment and biomechanical compression injury, and performed translational studies of AMPK pharmacologic activation.

Methods

We assessed activity (phosphorylation) of LKB1 and AMPKα in mouse knee OA cartilage, in aging mouse cartilage (6 to 24 months), and in chondrocytes after mechanical injury by dynamic compression, via immunohistochemistry or western blot. We knocked down LKB1 by siRNA transfection. Nitric oxide, matrix metalloproteinase (MMP)-3, and MMP-13 release were measured by Griess reaction and ELISA, respectively.

Results

Knockdown of LKB1 attenuated chondrocyte AMPK activity, and increased nitric oxide, MMP-3 and MMP-13 release (P <0.05) in response to IL-1β and TNFα. Both LKB1 and AMPK activity were decreased in mouse knee OA and aged knee cartilage, and in bovine chondrocytes after biomechanical injury. Pretreatment of bovine chondrocytes with AMPK activators AICAR and A-769662 inhibited both AMPKα dephosphorylation and catabolic responses after biomechanical injury.

Conclusion

LKB1 is required for chondrocyte AMPK activity, thereby inhibiting matrix catabolic responses to inflammatory cytokines. Concurrent loss of LKB1 and AMPK activity in articular chondrocytes is associated with OA, aging and biomechanical injury. Conversely, pharmacologic AMPK activation attenuates catabolic responses to biomechanical injury, suggesting a potentially novel approach to inhibit OA development and progression.

【 授权许可】

   
2013 Petursson et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140705094339630.pdf 2830KB PDF download
Figure 6. 49KB Image download
Figure 5. 46KB Image download
Figure 4. 81KB Image download
Figure 3. 117KB Image download
Figure 2. 25KB Image download
Figure 1. 49KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】
  • [1]Loeser RF, Goldring SR, Scanzello CR, Goldring MB: Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012, 64:1697-1707.
  • [2]Goldring MB, Goldring SR: Osteoarthritis. J Cell Physiol 2007, 213:626-634.
  • [3]Anderson DD, Chubinskaya S, Guilak F, Martin JA, Oegema TR, Olson SA, Buckwalter JA: Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J Orthop Res 2011, 29:802-809.
  • [4]Lotz M, Loeser RF: Effects of aging on articular cartilage homeostasis. Bone 2012, 51:241-248.
  • [5]Loeser RF: Aging and osteoarthritis. Curr Opin Rheumatol 2011, 23:492-496.
  • [6]Griffin TM, Guilak F: The role of mechanical loading in the onset and progression of osteoarthritis. Exerc Sport Sci Rev 2005, 33:195-200.
  • [7]Buckwalter JA, Martin JA, Brown TD: Perspectives on chondrocyte mechanobiology and osteoarthritis. Biorheology 2006, 43:603-609.
  • [8]Leong DJ, Hardin JA, Cobelli NJ, Sun HB: Mechanotransduction and cartilage integrity. Ann N Y Acad Sci 2011, 1240:32-37.
  • [9]Leong DJ, Sun HB: Events in articular chondrocytes with aging. Curr Osteoporos Rep 2011, 9:196-201.
  • [10]Steinberg GR, Kemp BE: AMPK in health and disease. Physiol Rev 2009, 89:1025-1078.
  • [11]Witczak CA, Sharoff CG, Goodyear LJ: AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 2008, 65:3737-3755.
  • [12]Salminen A, Hyttinen JM, Kaarniranta K: AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on health span and lifespan. J Mol Med 2011, 89:667-676.
  • [13]Terkeltaub R, Yang B, Lotz M, Liu-Bryan R: Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to inflammatory cytokines IL-1β and TNFα. Arthritis Rheum 2011, 63:1928-1937.
  • [14]Uhl M, Allmann KH, Ihling C, Hauer MP, Conca W, Langer M: Cartilage destruction in small joints by rheumatoid arthritis: assessment of fat-suppressed three-dimensional gradient-echo MR pulse sequences in vitro. Skeletal Radiol 1998, 27:677-682.
  • [15]Grogan SP, Miyaki S, Asahara H, D'Lima DD, Lotz MK: Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res Ther 2009, 11:R85. BioMed Central Full Text
  • [16]Carames B, Taniguchi N, Otsuki S, Blanco FJ, Lotz M: Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum 2010, 62:791-801.
  • [17]Liu R, Liote F, Rose DM, Merz D, Terkeltaub R: Proline-rich tyrosine kinase 2 and Src kinase signaling transduce monosodium urate crystal-induced nitric oxide production and matrix metalloproteinase 3 expression in chondrocytes. Arthritis Rheum 2004, 50:247.
  • [18]De Ceuninck F, Lesur C, Pastoureau P, Caliez A, Sabatini M: Culture of chondrocytes in alginate beads. Methods Mol Med 2004, 100:15-22.
  • [19]Salminen A, Kaarniranta K: AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res Rev 2012, 11:230-241.
  • [20]Turdi S, Fan X, Li J, Zhao J, Huff AF, Du M, Ren J: AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction. Aging Cell 2010, 9:592-606.
  • [21]Qiang W, Weiqiang K, Qing Z, Pengju Z, Yi L: Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKα. Exp Mol Med 2007, 39:535-543.
  • [22]Buckwalter JA, Martin JA: Osteoarthritis. Adv Drug Deliv Rev 2006, 58:150-167.
  • [23]Bohensky J, Leshinsky S, Srinivas V, Shapiro IM: Chondrocyte autophagy is stimulated by HIF-1 dependent AMPK activation and mTOR suppression. Pediatr Nephrol 2010, 25:633-642.
  • [24]Bohensky J, Shapiro IM: Autophagy: a new phase in the maturation of growth plate chondrocytes is regulated by HIF, mTOR and AMP kinase. Cells Tissues Organs 2009, 189:88-92.
  • [25]Carames B, Taniguchi N, Seino D, Blanco FJ, D'Lima D, Lotz M: Mechanical injury suppresses autophagy regulators and pharmacologic activation of autophagy results in chondroprotection. Arthritis Rheum 2012, 64:1182-1192.
  文献评价指标  
  下载次数:214次 浏览次数:12次